PRESCRIBING · PART D · 2024
Total Rx claims
353
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
12
Brand share
38.2%
Top prescribed drugs
Acyclovir82 claims
Sulfamethoxazole/Trimethoprim41 claims
Atovaquone38 claims
Prednisone32 claims
Ruxolitinib Phosphate31 claims
QUALITY · MIPS · 2024
Final MIPS score
88.5
Quality
87.1
Cost
69.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.57%
Group
REFERRAL NETWORK
Where Sally Arai's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Lori Muffly Hematopoietic Cell Transplantation and Cellular Therapy · Stanford, CA | 14 | 180 |
| Everett Meyer Hematopoietic Cell Transplantation and Cellular Therapy · Stanford, CA | 13 | 134 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE